| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6123335 | Journal of Infection | 2015 | 6 Pages |
Abstract
Only a small percentage of HBsAg-positive women are likely to meet the newly published criteria for antenatal anti-viral treatment. Strengthened community engagement across multiple ethnic groups is of paramount importance to improve maternal and infant outcomes.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
H.A. White, M.J. Wiselka, D.J. Wilson,